Colorectal carcinoma (CRC) is one of the leading causes of cancer-related deaths
worldwide, and up to 50% of patients with CRC develop colorectal liver metastases (CRLM) …

Background Approximately 30% of patients with colorectal cancer develop colorectal liver
metastases (CRLM). CRLM that become undetectable by imaging after chemotherapy are …

2.1 Geltungsbereich und Zweck 2.1. 1. Zielsetzung und Fragestellung Das Kolorektale
Karzinom (KRK) ist mit etwa 64 000 Neuerkrankungen und ca. 26 000 Todesfällen pro Jahr …

Background Owing to expanded surgical indications for colorectal liver metastasis (CRLM)
and improved systemic therapy, hepatic surgeons are increasingly faced with the problem of …

Background Laparoscopic liver surgery must reproduce open surgical steps. Intraoperative
ultrasonography (IOUS) is mandatory, but reliability of laparoscopic IOUS has been poorly …

The development of new potent systemic treatment modalities has led to a significant
increase in survival of patients with colorectal liver metastases. In the neo-adjuvant setting …

Colorectal cancer (CRC) is one of the commonest cancers with 1.2 million new cases
diagnosed each year in the world. It remains the fourth most common cause of cancer …

Background Hepatobiliary contrast enhanced MRI is known to be the most sensitive imaging
modality for detection of colorectal hepatic metastasis. To date no study has investigated the …

Background Clinical implication of disappearing liver metastases (DLMs) from colorectal
cancer after chemotherapy needs to be reviewed in the era of modern imaging studies …

Background. To assess the efficacy of intraoperative ultrasound (IOUS) compared with liver‐
specific magnetic resonance imaging (MRI) in patients with colorectal liver metastases …